← Back to Search

Quit Card Intervention for Cigarette Addiction (INITIATE Trial)

N/A

Waitlist Available

Led By Kerri-Anne Mullen, PhD

Research Sponsored by Ottawa Heart Institute Research Corporation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

≥ 18 years of age (the age of majority in Ontario)

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 26 weeks (6 months) after study enrollment

Awards & highlights

INITIATE Trial Summary

This trial is testing an intervention to help smokers quit in order to improve long-term abstinence and health outcomes. The intervention includes a behavioural incentive and tailored follow-up support.

Who is the study for?

This trial is for daily smokers aged 18+ in Ontario who smoke at least 5 cigarettes a day, are not critically ill, and can follow up for two years. They must have health insurance, access to phone or computer, understand English or French, and be able to consent.Check my eligibility

What is being tested?

The INITIATE Study tests a Quit Card Intervention (QCI) designed for emergency department settings. It aims to help smokers quit by combining behavioral incentives with tailored support over time while considering the fast-paced nature of EDs.See study design

What are the potential side effects?

While specific side effects aren't listed for QCI as it's behavior-based rather than drug-related, quitting smoking can lead to withdrawal symptoms like cravings, irritability, increased appetite, and restlessness.

INITIATE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

INITIATE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 26 weeks (6 months) after study enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~26 weeks (6 months) after study enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 26 weeks (6 months) after study enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Smoking Abstinence

Secondary outcome measures

Cessation Medication and/or E-cigarette Use

Cost-Effectiveness Ratios

Health Services Outcomes - Deaths

+8 more

INITIATE Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Quit Card Intervention (QCI)Experimental Treatment1 Intervention

Study intervention group.

Group II: Usual Care (UC)Active Control1 Intervention

Study control group.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Ottawa Heart Institute Research CorporationLead Sponsor

188 Previous Clinical Trials

91,228 Total Patients Enrolled

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,340 Previous Clinical Trials

26,451,490 Total Patients Enrolled

Kerri-Anne Mullen, PhDPrincipal InvestigatorOttawa Heart Institute Research Corporation

1 Previous Clinical Trials

210 Total Patients Enrolled

Media Library

Quit Card Intervention (QCI) Clinical Trial Eligibility Overview. Trial Name: NCT04163081 — N/A

Cigarette Addiction Research Study Groups: Usual Care (UC), Quit Card Intervention (QCI)

Cigarette Addiction Clinical Trial 2023: Quit Card Intervention (QCI) Highlights & Side Effects. Trial Name: NCT04163081 — N/A

Quit Card Intervention (QCI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04163081 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being recruited to partake in this clinical trial?

"Affirmative. Clinicaltrials.gov data reveals that this clinical trial, which was first published on April 19th 2022, is actively looking for participants. 1208 individuals are sought after by the two medical centres involved in this project."

Answered by AI

Is enrollment open to prospective participants at present?

"Affirmative. Information found on clinicaltrials.gov demonstrates that this medical trial, which was published in April of 2022, is currently recruiting participants. In total 1208 individuals need to be sourced from two separate clinics."

Answered by AI

Recent research and studies

TrialsJournal

The INITIATE Trial Protocol: A Randomized Controlled Trial Testing the Effectiveness of a “quit Card

Mullen, Kerri A., Aditi Garg, Frederick Gagnon, George Wells, Atul Kapur, Steven Hawken, Andrew L. Pipe, et al.. 2021. “The INITIATE Trial Protocol: A Randomized Controlled Trial Testing the Effectiveness of a “quit Card” Intervention on Long-term Abstinence Among Tobacco Smokers Presenting to the Emergency Department”. Trials. Springer Science and Business Media LLC. doi:10.1186/s13063-021-05693-9.

clinicaltrials.govStudy

The INITIATE Study: Initiating Nicotine Dependence Treatment for Smokers Admitted to Emergency Departments

2022. "The INITIATE Study: Initiating Nicotine Dependence Treatment for Smokers Admitted to Emergency Departments". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04163081.